Loading people...
Jonathan Mandelbaum is a Principal on the private equity team at OrbiMed in New York City, where he specializes in life sciences, biotechnology, and healthcare investments. Since joining the $17 billion global investment firm in 2020, he has focused heavily on financing early-stage biopharmaceutical and medical device companies, which includes serving as a board member for Triveni Bio. Before his current tenure at OrbiMed, Mandelbaum worked at Accelerator Life Science Partners, where he concentrated his efforts on early-stage biopharmaceutical company creation and strategic development. Prior to entering the venture capital sector, he served as a dedicated research scientist specializing in oncology drug discovery at Millennium Pharmaceuticals. He earned a Bachelor of Science from McGill University and a PhD in Cellular, Molecular, and Biophysical Studies from Columbia University, leveraging this extensive scientific background to evaluate innovative therapeutic platforms.
Jonathan Mandelbaum is a distinguished Senior Associate at OrbiMed, a globally recognized investment firm exclusively dedicated to the healthcare sector. With a robust background in finance and a deep understanding of life sciences, Jonathan is integral to OrbiMed's strategic initiatives in identifying and nurturing promising companies across the healthcare landscape. His role involves critical analysis, due diligence, and supporting investment decisions that drive innovation in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services.
At OrbiMed, Jonathan Mandelbaum contributes to a team that manages billions in assets across public equity, private equity, and venture capital strategies. This diverse approach allows OrbiMed to invest in companies at various stages of development, from early-stage startups pioneering groundbreaking therapies to established market leaders. Jonathan's expertise helps OrbiMed navigate the complexities of the healthcare market, focusing on opportunities that offer significant potential for both financial returns and positive impact on global health. He is actively involved in market research, financial modeling, and assessing the scientific and commercial viability of potential investments, ensuring that OrbiMed's capital is deployed effectively to support transformative healthcare solutions.
Jonathan's career trajectory before joining OrbiMed provided him with a strong foundation for his current role. He honed his financial acumen as an Investment Banking Analyst in the Healthcare Group at J.P. Morgan. This experience equipped him with invaluable skills in financial analysis, transaction execution, and understanding the intricate dynamics of the healthcare industry from a corporate finance perspective. His work at J.P. Morgan involved advising pharmaceutical, biotechnology, and medical technology companies on mergers, acquisitions, and capital raises, giving him a comprehensive view of the sector's financial ecosystem.
Academically, Jonathan Mandelbaum possesses a unique blend of scientific and economic knowledge, which is highly advantageous in healthcare investment. He earned a Bachelor of Science in Economics with concentrations in Finance and Healthcare Management from the Wharton School at the University of Pennsylvania. Concurrently, he also completed a Bachelor of Arts in Biology from the University of Pennsylvania. This dual academic background provides him with the ability to critically evaluate both the scientific merits of new technologies and the financial implications of healthcare ventures. This interdisciplinary approach is crucial for making informed investment decisions in a sector driven by scientific breakthroughs and complex market dynamics.
While specific individual "notable investments" are typically attributed to partners or funds rather than individual senior associates, Jonathan Mandelbaum's contributions are vital to OrbiMed's overall success in its investment activities. He plays a significant role in the rigorous evaluation process that underpins OrbiMed's portfolio, helping to identify companies poised for growth and innovation. His dedication to understanding the evolving healthcare landscape ensures that OrbiMed continues to be a leader in funding the next generation of medical advancements.
Jonathan Mandelbaum is a Senior Associate at OrbiMed, a leading global investment firm focused exclusively on the healthcare sector. He plays a key role in evaluating and executing investment opportunities across life sciences.
As part of OrbiMed's team, Jonathan Mandelbaum focuses on investments within the broader healthcare sector, including biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services.
Jonathan Mandelbaum works at OrbiMed, a prominent global investment firm dedicated to financing and supporting companies in the healthcare industry.
